SEC 13F Intelligence

Bourgeon Capital Management LLC / TEVA

Bourgeon Capital Management LLC’s Teva Pharmaceutical Inds Ltd Position

Does Bourgeon Capital Management LLC own Teva Pharmaceutical Inds Ltd (TEVA)? Yes286.3K shares worth $9M (+1.49% of its 13F portfolio) as of Q1 2026, down from 611.3K shares the prior filed quarter.

Position Value
$9M
Q1 2026
Shares
286.3K
% of Portfolio
+1.49%
Quarters Held
12
currently held

Position History TEVA

Reported value by quarter
Q2 ’23: $5MQ2 ’23Q3 ’23: $7MQ4 ’23: $7MQ4 ’23Q1 ’24: $9MQ2 ’24: $11MQ2 ’24Q3 ’24: $12MQ4 ’24: $15MQ4 ’24Q1 ’25: $6MQ2 ’25: $12MQ2 ’25Q3 ’25: $15MQ4 ’25: $19MQ4 ’25Q1 ’26: $9Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026286.3K$9M+1.49%
Q4 2025611.3K$19M+3.09%
Q3 2025720.0K$15M+2.63%
Q2 2025724.0K$12M+2.39%
Q1 2025360.7K$6M+1.19%
Q4 2024660.0K$15M+2.72%
Q3 2024663.3K$12M+2.30%
Q2 2024668.3K$11M+2.13%
Q1 2024665.1K$9M+1.84%
Q4 2023658.6K$7M+1.52%
Q3 2023661.6K$7M+1.58%
Q2 2023651.8K$5M+1.14%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bourgeon Capital Management LLC’s full portfolio or all institutional holders of TEVA.